1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Biomarkers in mesothelioma and non-small cell lung cancer - Investigation of cytological specimens with correlation to histology
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2022
-
Mark
Quantitative Proteomics Indicate Radical Removal of Non-Small Cell Lung Cancer and Predict Outcome
(
- Contribution to journal › Article
- 2021
-
Mark
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response
(
- Contribution to journal › Article
- 2020
-
Mark
Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects
(
- Contribution to journal › Article
-
Mark
Epigenome-wide gene-age interaction analysis reveals reversed effects of PRODH DNA methylation on survival between young and elderly early-stage NSCLC patients
(
- Contribution to journal › Article
- 2019
-
Mark
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11
(
- Contribution to journal › Article
- 2018
-
Mark
Genomic characterization of non-small cell lung cancer - clinical and molecular implications
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Apolipoprotein M promotes proliferation and invasion in non-small cell lung cancers via upregulating S1PR1 and activating the ERK1/2 and PI3K/AKT signaling pathways
(
- Contribution to journal › Article
- 2013
-
Mark
Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy
(
- Contribution to journal › Article
- 2012
-
Mark
Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer
(
- Contribution to journal › Article